Production (Stage)
Zai Lab Limited
ZLAB
$31.32
-$1.18-3.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.37% | 6.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.37% | 6.65% | |||
| Cost of Revenue | 5.33% | -8.31% | |||
| Gross Profit | -51.71% | 2,422.87% | |||
| SG&A Expenses | -23.23% | 22.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.00% | 4.02% | |||
| Operating Income | 17.06% | -0.06% | |||
| Income Before Tax | 40.70% | -96.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.70% | -96.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.70% | -96.02% | |||
| EBIT | 17.06% | -0.06% | |||
| EBITDA | 18.51% | 0.19% | |||
| EPS Basic | 43.66% | -87.40% | |||
| Normalized Basic EPS | 45.88% | -91.60% | |||
| EPS Diluted | 43.66% | -87.40% | |||
| Normalized Diluted EPS | 45.88% | -91.60% | |||
| Average Basic Shares Outstanding | 5.26% | 4.60% | |||
| Average Diluted Shares Outstanding | 5.26% | 4.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||